Andres Maldonado HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
55
Avg Return
Past Year
Past Year
9.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
94.1%
Neutral
5.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $40 |
121%
upside
| 2 | +32% |
0
%
| 20 Oct ‘25 yesterday |
|
|
|
Buy
Assumed
| $40 |
158%
upside
| 1 | +3.8% |
0
%
| 16 Oct ‘25 5 days ago |
|
|
|
Neutral
Downgraded
| $97 |
3%
upside
| 1 | – |
–
| 30 Sep ‘25 21 days ago |
|
|
|
Buy
Reiterated
| $23 |
318%
upside
| 1 | -2.5% |
0
%
| 29 Sep ‘25 22 days ago |
|
|
|
Buy
Maintained
| $105 |
35%
upside
| 2 | +76% |
0
%
| 29 Sep ‘25 22 days ago |
|
|
|
Buy
Maintained
| $44 |
54%
upside
| 1 | +2.5% |
0
%
| 23 Sep ‘25 28 days ago |
|
|
|
Buy
Reiterated
| $75 |
74%
upside
| 3 | +2% |
0
%
| 15 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $25 |
167%
upside
| 2 | +15% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $8 |
228%
upside
| 1 | -1.6% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $7 |
40%
upside
| 1 | +59% |
0
%
| 21 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $22 |
269%
upside
| 1 | +0.37% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
31%
upside
| 1 | +14% |
0
%
| 8 Aug ‘25 2 months ago |
|